Krystal Biotech's market cap is currently $5.25B. The company's EPS TTM is $1.29; its P/E ratio is 36.92; Krystal Biotech is scheduled to report earnings on August 4, 2025, and the estimated EPS forecast is $1.09. See an overview of income statement, balance sheet, and cash flow financials.
